Date: 2012-02-16
Type of information: R&D agreement
Compound: integrated drug discovery solutions
Company: Evotec (Germany) IR Pharma (UK)
Therapeutic area: Respiratory diseases
Type agreement: R&D
collaboration
Action mechanism:
Disease:
Details: Evotec AG and IR Pharma have entered into an exclusive strategic alliance to provide integrated drug discovery solutions to Pharmaceutical and Biotech companies in the field of Respiratory Diseases. This alliance expands Evotec’s already powerful drug discovery platform, into the area of respiratory diseases through IR Pharma’s world leading expertise in in vitro and in vivo Respiratory pharmacology. As part of this exclusive collaboration, Evotec is now positioned to offer seamless, fully integrated respiratory and inflammation focused drug discovery programmes to its partners, from target to nomination of pre-clinical development candidates.
Financial terms: Financial details were not disclosed.
Latest news:
